Acute myeloid leukemia in the elderly: do we know who should be treated and how? - Wikidata - wikimedia - TriplyDB

Acute myeloid leukemia in the elderly: do we know who should be treated and how?

Acute myeloid leukemia in the elderly: do we know who should be treated and how?

http://www.wikidata.org/entity/Q38124066

about

The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabine A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome.Acute myeloid leukemia: advancing clinical trials and promising therapeutics.Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells.Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia.Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia.AML therapy in the elderly: a time for a change.The changing face of acute myeloid leukemia therapeutics in the elderly population.Comorbidity, Physical Function, and Quality of Life in Older Adults with Acute Myeloid Leukemia.Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?Clinical decision making in cancer care: a review of current and future roles of patient age.

P2860

Q34979606-A6FD6C28-9ACE-497E-8E9B-5AF2016DE77F Q36682845-ED9EAD84-2F60-45E4-B23F-511FB0916F85 Q37221579-33DDD79B-1D50-4E8B-9C9F-E535C29AD764 Q37278653-C9C118E4-F1D3-49C9-BB9F-F67033FE75D2 Q37310474-5A491D3E-8C39-476A-8753-3BEA4D5FC5AA Q38850054-84F4E377-D198-4FE5-8A61-CDCEB1DD896B Q39311595-542ECC01-0548-44F8-A22F-F020F51576E7 Q40376093-A6212B05-180C-4E28-AE67-665DC9BECECB Q40813160-FB1D6EDA-5928-46AE-A889-EFAD27140192 Q41763410-580F3F18-7907-427E-928F-506940600134 Q50234387-68D270C1-6E96-4C97-B86F-131C42C886C7 Q53804314-E11F2E4B-1C3C-4604-B8DB-6270D5412FF0 Q55135907-2028587F-EE2C-4572-882C-757F6824EE37

P2860

Acute myeloid leukemia in the elderly: do we know who should be treated and how?

http://www.wikidata.org/entity/Q38124066

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Acute myeloid leukemia in the elderly: do we know who should be treated and how?

@en

type

label

Acute myeloid leukemia in the elderly: do we know who should be treated and how?

@en

prefLabel

Acute myeloid leukemia in the elderly: do we know who should be treated and how?

@en

P1433

Q38124066-351D88E6-2823-493E-B2E1-CDE39F22C88A

P1476

Q38124066-284A9DFB-ECD8-4317-B0F5-677719FC448C

P2093

Q38124066-95C8A4A8-F806-42E9-A729-732D91E4A9C5

P2860

Q38124066-07FE548A-3F0F-4E5B-B568-B83DEE611B4A

Q38124066-0EDB888D-3790-4032-8676-B6B030FC2174

Q38124066-140F728D-B8FF-494F-B950-CEA55FFE7F18

Q38124066-14C19834-6A91-4F78-9515-83291FAE738A

Q38124066-1567177A-463F-48F1-ADAB-A0236AFB5888

Q38124066-17C6E342-1D34-4273-95C2-DEF1F885DF44

Q38124066-230F5AA4-1E80-4E3D-9E8D-7100F19E44E4

Q38124066-23C8892C-E4A4-4B89-B59E-CAAE47C16E84

Q38124066-2E129FDD-E611-4732-B944-47E8A2F406FA

Q38124066-3446B9BA-837A-42E5-8940-18E0E6472333

P304

Q38124066-268199C7-0D37-41EE-A374-DDA570CFF21E

P31

Q38124066-8DE41945-B31C-40BD-9F57-C8C5F0E07AB5

P356

Q38124066-8C92CE3D-AFC2-4329-B721-E947B0764F56

P433

Q38124066-2FF221B1-D046-48B3-ABA7-EA328D48EE8F

P478

Q38124066-F9C928E4-177E-4D7D-8E0F-677341EB96E7

P50

Q38124066-7F6372BC-9307-43A4-8584-DE6FA25C17A6

P577

Q38124066-86AC6262-D2F6-49E7-997B-23E091B12295

P698

Q38124066-90DDD88C-397C-463F-98B2-DF889484B83D

P932

Q38124066-CB1E09DB-66C6-4C52-9DAF-348C0F03062E

P356

10428194.2013.828348

P1433

Leukemia & Lymphoma

P1476

Acute myeloid leukemia in the elderly: do we know who should be treated and how?

@en

P2093

Aziz Nazha

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Cancer statistics, 2006

Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial.

P304

979-987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2013.828348

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23885839

http://www.w3.org/2001/XMLSchema#string

P932

4111566

http://www.w3.org/2001/XMLSchema#string